Now ketamine, a glutamatergic NMDA receptor antagonist, may provide a mechanism that could link these pathways. Figure 1: A schematic of how ketamine may lead to an overall excitation in the cortex.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glutamatergic medications showed promise in treating obsessive-compulsive and related disorders (OCRDs), especially ...

Glutamatergic medications showed promise in treating obsessive-compulsive and related disorders (OCRDs), especially obsessive-compulsive disorder (OCD), a systematic review and meta-analysis ...